AJP Legacy AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol 203: 671-675, 1962;
0002-9513/62 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleisch, H.
Right arrow Articles by Bisaz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleisch, H.
Right arrow Articles by Bisaz, S.

Isolation from urine of pyrophosphate, a calcification inhibitor

Herbert Fleisch 1 and Sylvia Bisaz 1

1 Departments of Physiology and Surgery, University of Lausanne, Lausanne, Switzerland

The minimum value of the product, Ca X P, necessary for calcium phosphate precipitation to occur, was determined in vitro. The addition of 2.2% urine to the solutions raised the mean product from 53 to 105 (mg/100 ml)2, which shows that the urine contains inhibitors to hydroxyapatite precipitation. One of these was isolated and purified. Its characteristics are those of inorganic pyrophosphate. The mean level of urinary pyrophosphate was 2.24 mg P/liter, sufficient to inhibit precipitation of hydroxyapatite. Pyrophosphate is one of the substances permitting urine to be supersaturated with calcium and phosphate; other urinary inhibitors are still to be identified. It is suggested that the phosphate compound present in the plasma which inhibits hydroxyapatite precipitation is pyrophosphate. In bone, pyrophosphatase would act by locally destroying this calcification inhibitor, thus allowing the apatite crystals to form.

Submitted on February 9, 1962




This article has been cited by other articles:


Home page
 Exp PhysiolHome page
S. H. Moochhala, J. A. Sayer, G. Carr, and N. L. Simmons
Renal calcium stones: insights from the control of bone mineralization
Exp Physiol, January 1, 2008; 93(1): 43 - 49.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. N. Addison, F. Azari, E. S. Sorensen, M. T. Kaartinen, and M. D. McKee
Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity
J. Biol. Chem., May 25, 2007; 282(21): 15872 - 15883.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. G. G. Russell
Bisphosphonates: Mode of Action and Pharmacology
Pediatrics, March 1, 2007; 119(Supplement_2): S150 - S162.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
A. A Licata
Discovery, Clinical Development, and Therapeutic Uses of Bisphosphonates
Ann. Pharmacother., April 1, 2005; 39(4): 668 - 677.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
H. Fleisch
Bisphosphonates: Mechanisms of Action
Endocr. Rev., February 1, 1998; 19(1): 80 - 100.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1962 by the American Physiological Society.